Israeli Startup NeuraLight Raises $25M For Its AI Neurological Platform
NeuraLight leverages computer vision to extract all relevant oculometric markers from facial videos recorded with a webcam or smartphone.
May 26, 2022
Technion Scientists Develop Molecule That Could Slow Down Alzheimer’s Disease
The molecule developed by French and Israeli researchers is the foundation for the future development of peptoids as drugs for Alzheimer's.
November 18, 2021
TAU Study Shows Cognitive Boost In Alzheimer’s Patients Using Oxygen Therapy
An Israeli team of investigators remarked that this was the first time that non-drug therapy has been proven effective.
September 26, 2021
Israeli Neuroscientist’s New Alzheimer’s Treatment To Head For Clinical Trial
If the Alzheimer's treatment is successful, it could be a game-changer for the disorder, modifying its course and preventing its progression.
October 06, 2020
Experimental Alzheimer’s Drug May Help Kids With Autism, Says Leading Israeli Neuroscientist
The study, headed by researchers from Tel Aviv University, sheds light on the effects of ADNP syndrome, a condition on the autism spectrum.
August 10, 2020
Israeli Researchers Gaze Into The Eyes To Detect Alzheimer’s Disease Early
Israel's Sheba team believes eyes are windows to our brain and could help detect the devastating illness.
August 08, 2017
Breakthrough Blood Test For Alzheimer’s Disease To Undergo Clinical Trials
A new discovery by Israeli and American researchers seeks to effectively screen and diagnose Alzheimer's through simple blood tests.
April 04, 2016
Understanding Gender Differences Could Improve Autism And Alzheimer’s Treatment
Were all men and women created equal? Not according to a new study, which suggests that diseases are formed differently in males in females.
March 22, 2015
Israeli Company ‘Neuronix’ Offers Hope For Alzheimer’s Disease With Unique Treatment
Neuronix has developed what may be the most advanced non-invasive treatment for Alzheimer's Disease. The company says its treatment can restore a patient's cognitive ability to a state comparable to that of two years before treatment.
August 25, 2013